APA

Mälarstig A., Lindahl B., Wallentin L. & Siegbahn A. (20060718). Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. : Arteriosclerosis, thrombosis, and vascular biology.

Chicago

Mälarstig Anders, Lindahl Bertil, Wallentin Lars and Siegbahn Agneta. 20060718. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. : Arteriosclerosis, thrombosis, and vascular biology.

Harvard

Mälarstig A., Lindahl B., Wallentin L. and Siegbahn A. (20060718). Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. : Arteriosclerosis, thrombosis, and vascular biology.

MLA

Mälarstig Anders, Lindahl Bertil, Wallentin Lars and Siegbahn Agneta. Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome. : Arteriosclerosis, thrombosis, and vascular biology. 20060718.